Jump Financial LLC Acquires 891 Shares of McKesson Co. (NYSE:MCK)

Jump Financial LLC grew its position in McKesson Co. (NYSE:MCK - Free Report) by 48.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,727 shares of the company's stock after purchasing an additional 891 shares during the period. Jump Financial LLC's holdings in McKesson were worth $1,554,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in MCK. Millstone Evans Group LLC bought a new stake in shares of McKesson in the fourth quarter worth about $28,000. Synergy Asset Management LLC bought a new stake in McKesson during the 4th quarter worth approximately $32,000. Crews Bank & Trust bought a new position in McKesson in the fourth quarter valued at approximately $33,000. Atala Financial Inc acquired a new position in shares of McKesson in the fourth quarter valued at approximately $34,000. Finally, Graney & King LLC bought a new stake in shares of McKesson in the fourth quarter worth $38,000. 85.07% of the stock is owned by institutional investors.

Insider Buying and Selling at McKesson

In other news, CEO Brian S. Tyler sold 8,961 shares of the stock in a transaction dated Friday, February 21st. The shares were sold at an average price of $597.99, for a total transaction of $5,358,588.39. Following the transaction, the chief executive officer now owns 60,664 shares of the company's stock, valued at $36,276,465.36. This represents a 12.87 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Leann B. Smith sold 188 shares of the stock in a transaction that occurred on Wednesday, February 12th. The stock was sold at an average price of $609.59, for a total value of $114,602.92. Following the completion of the transaction, the executive vice president now owns 1,051 shares in the company, valued at approximately $640,679.09. The trade was a 15.17 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 18,110 shares of company stock worth $10,855,706. Insiders own 0.11% of the company's stock.

McKesson Trading Up 0.1 %

McKesson stock traded up $0.96 during midday trading on Friday, reaching $689.39. The company's stock had a trading volume of 220,884 shares, compared to its average volume of 889,132. The stock has a market cap of $86.40 billion, a PE ratio of 31.56, a price-to-earnings-growth ratio of 1.29 and a beta of 0.49. McKesson Co. has a 52 week low of $464.42 and a 52 week high of $728.32. The business has a 50-day moving average price of $659.36 and a 200-day moving average price of $605.06.

McKesson (NYSE:MCK - Get Free Report) last issued its earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing analysts' consensus estimates of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. As a group, research analysts predict that McKesson Co. will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Monday, March 3rd were issued a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a yield of 0.41%. The ex-dividend date was Monday, March 3rd. McKesson's payout ratio is presently 13.00%.

Analysts Set New Price Targets

MCK has been the topic of several research analyst reports. Mizuho increased their price objective on shares of McKesson from $630.00 to $690.00 and gave the company a "neutral" rating in a research report on Thursday, April 3rd. Citigroup reduced their price objective on McKesson from $713.00 to $677.00 and set a "buy" rating for the company in a report on Friday, January 10th. StockNews.com lowered McKesson from a "strong-buy" rating to a "buy" rating in a research note on Friday, February 14th. Evercore ISI boosted their price target on McKesson from $650.00 to $675.00 and gave the company an "outperform" rating in a research note on Thursday, February 6th. Finally, Cfra Research lowered McKesson from a "moderate buy" rating to a "hold" rating in a report on Friday, April 4th. Three equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $668.50.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.